Apellis Pharmaceuticals, Inc.

Delisted

CIK 1492422fmd_15HFQXXZ5ZYZ3SR7E9YQ7D6QZ3Manufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2015 to Mar 31, 2026, 42 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).